Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
All systems go. Ready to Launch!
The antennas are already in place as it uses existing radio infrastructure. All that is needed is the q-term platform and the sensing device which are full developed but in the testing and implementation phase.
Take notice bottom fishers, it’s time to throw in your lines for the big catch!
Load up, this pressure cooker is about to explode!
Since there is no known cure for pancreatic cancer, the success of this drug to cure pancreatic cancer would be a godsend!
They announced the submission on Jan 27th, but, as you indicated, the submission may have occurred earlier.
That would be nice and would move the timeline up to the end of this month!
That would be nice!
Uplisting to OTC-QB takes 45 to 60 days after the application is submitted. This would mean the uplisting should occur sometime during the last two weeks of March.
So whatever the share price is in March, I predict the uplisting will increase the price by 30% on the day the uplisting is announced.
If it’s sitting at .30, it will go to .40. JMHO!
Yep! Shorts held it down but couldn’t drive it down. Very Telling!
The volume says it all. It’s reached 7 million traded shares which is seventy times normal. Usually huge volume occurs before a huge price upside.
Got my 300K picked up 100K more this past week at bargain prices. I will buy more at .10, but don’t expect to see that price again.
Saw the MM’s walk it down. They got it to .088. I could not believe it. Once the MM’s got out of the way, it popped up fast. Should see 0.15 on Monday and a nice start on its way up to .50. JMHO!
Good News For Shareholders
Sunshine Biopharma has moved out of the invitro (in-glass) test tube phase of the study of its Covid 19 compound into the next phase, the testing of the compound in mice.
That implies the invitro testing was a success. Otherwise it would not be moving to the next level and the licensing agreement with UGA to conduct further studies on mice would not have been signed.
Bottom Fishing. This will only go up.
Big News!
My guess, End of Day: .50
“The run has begun!”
Used to work in the semiconductor industry. Getting product to market fast is the key to success due to the short term product obsolescence of a wafer.
The ability to produce a wafer using AI microtechnology to shorten the design time prior to full scale production will have immense benefits to the semiconductor fabricators.
Expect this stock to breakout today. My estimate is .10 by Friday. JMHO!
This would be terrific solution for Alzheimer's patients who are mentally impaired and have a tendency to walk out of homes without notice. Tracking parolees released on good behavior. This would also be a terrific device to detect child abduction of babies from hospital nurseries. Tracking and monitoring patients locations and vitals as they move about a hospital. Tracking critical life saving equipment in a hospital setting, ventilators, defibrillators, and more to inventory those being used and those available to get the available life saving equipment to patients in need quickly.
Very simple installation to get this up and running. Just plug the transceiver into a network hub, attach the device to the dog, child patient, parolee, equipment and your on your way. Good for up to ten miles from your transceiver.
https://www.indiegogo.com/projects/guardian-orb-the-most-advanced-pet-tracker#/
The article below provides the sales figures of the Guardian Orb "pet tracker" when it was first introduced. Have "no idea" what the revenue stream from this product is currently.
What's important is that this technology can be applied to other applications like mobile tracking of a patient's vital signs which is exactly what they are working on as we speak. They can piggyback the Guardian Orb technology to finding a roaming pet to tracking a patient's vitals or finding a buried skier in an avalanche, hikers in unfamiliar surroundings, or placing a wristband on your child at a theme park. They are just scratching the surface here when it comes the many variety of applications.
Gopher Completed Guardian ORB System FCC and CE Certification
Made its First Production Order for its Indiegogo Customers – More than
$63,000 in Pre-Sales in Only Two Months
SAN DIEGO, CA., July 12, 2018 (GLOBE NEWSWIRE) -- Gopher Protocol Inc.
(OTCQB: GOPH) ("Gopher"), a company specializing in the creation of Internet
of Things (IoT) and Artificial Intelligence enabled mobile technologies, is
pleased to announced It completed its Guardian ORB system FCC and CE
certification. We tested the product radio frequency (RF) characteristics to
ensure safety levels and interference free operation according to US and
European standards. The FCC Declaration of Conformity is a certification
mark employed on electronic products manufactured or sold in the United
States which certifies that the electromagnetic interference from the device
is under limits approved by the Federal Communications Commission. The Federal
Communication Commission is an agency of the US federal government, created to
regulate all forms of telecommunications, radio, TV, telephony, and similar RF
based devices. Its mandate is to develop and enforce safety, health and
interference rules of telecommunications devices. RF devices are required to
be properly authorized by the FCC prior to being marketed or imported into the
United States.
The CE certification is the US FCC equivalent standards in Europe. CE
marking is a certification mark that indicates conformity with health, safety,
and environmental protection standards for products sold within the European
Economic Area (EEA). The European Commission describes the CE mark as a
"passport" that allows manufacturers to circulate industrial products freely
within the internal market of the EU. The CE mark certifies that the products
have met EU health, safety and environmental requirements that ensure consumer
and workplace safety.
Gopher also makes its first order for the benefit of its Indiegogo campaign
backers that ordered our Guardian ORB system for the past few months. We are
happy to support our first customers by providing our first product that
encapsulate our technology. The products will be delivered to our customers
within the next few months. Guardian Orb generated pre-sales more than $63,000
within two months
- https://www.indiegogo.com/projects/guardian-orb-the-most-advanced-pet-tracker-pets#/
"We are paying extra attention to our radio devices safety and harmless
operation within the US and around the world" provided Dr. Danny Rittman,
Gopher's CTO. "That is why we certified our custom battery, and modified our
product's printed circuit boards (PCB) in order to ensure the world's safety,
health and communication standards. Radio waves are forms of electromagnetic
radiation — waves of energy that travel at the speed of light. It is important
for us to ensure proper safety levels and radio standards in order to use our
technology without causing any harm to humans and to our environment. Gopher
is focusing to create green technology that does not harm our environment and
provide new capabilities for the IoT domain. In our modern age, when our
planet is at constant ecological risks we make sure that our technology is
ecofriendly for the safety of people and our environment. We believe our
Indiegogo campaign was a success and we are now making the first order for our
first customers to be delivered within the next few months" added Dr. Rittman.
About Gopher Protocol Inc.
Gopher Protocol Inc. (OTCQB: GOPH) (“Gopher”) (http://gopherprotocol.com/) is
a development-stage company which consider itself Native IoT creator,
developing Internet of Things (IoT) and Artificial Intelligence enabled
mobile technology. Gopher has a portfolio of Intellectual Property that when
commercialized will include smart microchips, mobile application software and
supporting cloud software. The system contemplates the creation of a global
network. The core of the system will be its advanced microchip technology
that can be installed in any mobile device worldwide. Gopher envisions this
system as an internal, private network between all enabled mobile devices
providing shared processing, advanced mobile database management/sharing and
enhanced mobile features.
Corporate Site: http://gopherprotocol.com
Press page/ press kit - http://gopherprotocol.com/?page_id=228
Consumer and product website for Guardian
Patch: http://www.guardianpatch.com/.
About Guardian Pet Tracker http://www.guardianpettracker.com/
The Guardian Pet Tracker (Sphere Internal name - the "Sphere") system is a
derivative technology of Gopher's Guardian Patch technology. The Sphere is
designed to provide its users with local tracking capability using a
re-chargeable/replaceable battery source. Gopher intends to release
pre-production units in limited test in the near future.
Announcement of the Farmshare LLC purchase in LaGrange, NC would have to occur soon so they could get the hemp planted in the spring.
If the deal goes through in the immediate future, this stock should see a nice increase in its share price. The deal is based on a transfer of stock and a promissory note according to the news byte published back on November 30, 2020.
There has been a short squeeze on this stock for over two weeks. I anticipate GTCH will rocket up today as the shorts are forced to cover. This stock, in my humble opinion, will likely double its share price today. They were just listed on the, “Short Squeeze Report.” JMHO!
GTCH Predicted to run!
InvestorWallet projects stock PPS to rise to .13 by The first week in February!
GBT Seeks FDA Approval for its qTerm Device
GBT Technologies Inc.
January 12, 2021
SAN DIEGO, Jan. 12, 2021 (GLOBE NEWSWIRE) -- GBT Technologies Inc. (OTC PINK: GTCH) ("GBT”, or the “Company”) announced that GBT Tokenize Corp (“GBT/Tokenize”) it is seeking approval filing for its qTerm device with the United States Food and Drug Administration (“FDA”).
The qTerm, a human vitals device powered by AI, is aimed to measure human vitals with a touch of a finger. The device received its Trademark allowance notice and will present it on the product/package as required by the United States Patent Office (“USPTO”). In its first release, the qTerm device is targeted to measure body temperature, blood oxygen level and heart rate. In the next release, GBT/Tokenize plans to add a blood pressure feature. qTerm device will be accompanied by a smartphone app and web application that will keep a history for the user's records, providing a geographical proximity alert and record statistical data about the user's vitals.
Electronic medical devices that perform complex functions to assist with diagnosis, and monitoring health conditions require an FDA approval. It is important to demonstrate the device's functionality, safety, and biocompatibility. The FDA classifies medical devices from Class 1 – 3, each of which must be subjected to robust evaluations and reviews to comply with manufacturing quality control (QC) standards. The FDA regulates the marketing/sale of medical device products in the U.S. and monitors the safety of all regulated medical products. FDA Section 201(h) of the Food, Drug & Cosmetic Act (FD&C Act) defines a device as: an instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent, or other similar or related article, including a component part or accessory which is recognized in the official National Formulary, or the United States Pharmacopoeia, or any supplement to them, intended for use in the diagnosis of disease or other conditions, or in the cure, mitigation, treatment, or prevention of disease in man or other animals, or intended to affect the structure or any function of the body of man or other animals. (*)
It is intended that the device will be filed under PART 880 -- GENERAL HOSPITAL AND PERSONAL USE DEVICES, Subpart C - General Hospital and Personal Use Monitoring Devices as a clinical electronic device that is used to measure body vital of a patient by means of a transducer coupled with an electronic signal amplification, conditioning, and display unit. The device's classification is estimated to be Class I/II and it is expected that it will be determined by the FDA further review. FDA approval means formal approval as a medical device to be marketed and sold in the U.S. This type of certification is essential to ensure the device's safety, accuracy, and effectiveness for public use.
"We seek to have our qTerm human vitals device approved by the FDA to confirm high standards and compliance. Another aspect is to gain potential customer's confidence and trust in the product's performance and accuracy. We plan to offer the technology for personal, hospitals and clinics usage and seeking to comply with the industry's standards and regulations. FDA approval means that the FDA has formally approved the qTerm product to be safe and effective for market and sale in the U.S. Our qTerm device is an external, non-invasive device that is targeted to measure human vitals. In addition, we believe that its main advantage upon similar products is its Artificial Intelligence technology that offers advanced features like real-time health statistics, analytics, and monitoring. The device is designed to assist in potential illness prevention by providing a real time, geographically proximity alert. It is easy for use, and mainly intuitive. We believe that this type of device can become a personal health assistant monitoring, analyzing, and alerting for potential issues in real time. Early detection of potential health issues, based on vitals can be crucial and a life saver. Applying for an FDA clearance is a long process but we strongly believe it will bring our technology to the highest standards to be used by hospitals and individuals," said Danny Rittman, CTO of GBT Technologies.
GBT Tokenize Develops New Radio System for qTerm Device
GBT Technologies Inc.
November 9, 2020·3 min read
Targeting the Creation of a Private, Secured MESH Network
SAN DIEGO, Nov. 09, 2020 (GLOBE NEWSWIRE) -- GBT Technologies Inc. (OTC PINK: GTCH) ("GBT”, or the “Company”), announced that GBT Tokenize (“GBT/Tokenize”) commenced a new radio system development for its qTerm device.
The new radio system is aimed to enable qTerm as a private, secured, MESH radio communication network. GBT/Tokenize has developed the technology for a radio based network that can be used for IoT and mobile devices. A successful MESH network system was tested in 2019.
This new radio system will be implemented as communication circuits to enable direct communication between qTerm devices outside the BLE (Low Energy Bluetooth) radio system. The system is planned to communicate using its own radio channel, creating a MESH network between qTerm devices and will work within its own, private, secured communication protocol.
GBT/Tokenize is now checking the best radio frequencies to be used starting at 0.1hz up to 20Mhz range. The new circuit is planned to sweep frequencies within a designated range, in order to enhance data security and signal reliability. In addition, the signals are planned to be encrypted and working in 2-way handshake protocol. The radio system will be miniaturized in order to fit within qTerm device size. Another crucial aspect is to operate in low power consumption to maintain long battery life. The system is planned to “sleep” most of the time, wakeup according to an advanced algorithm, transmit its signals and go back to “sleep”. The development will focus on efficient range, high security and low power consumption. GBT is planning to integrate this new radio system within its qTerm during 2021, enabling additional, future features for the user's benefits.
"We have extensive experience, developing innovative radio technologies and we used them for tracking and IoT/Mobile concepts. We decided to test implementation of this radio platform within qTerm device to create another layer of advanced communication and offer future, additional features" stated Danny Rittman, GBT CTO. "We are now checking efficient frequencies for device communication, facing the challenge of low power consumption and long range. Another challenge will be the miniaturization of this radio system in order to fit within our qTerm device size. Since the system is planned to work with and without GPS, we believe it can save lives by bypassing the BLE system, transmitting, radio based emergency alert and location information. We already built an alpha version device to assess radio frequencies regarding power and range. The design is planned to continue throughout 2021."
No, I worked with Ellerbe Beckett in Washington DC.
Singapore Population 5.7 Million, second to Hong Kong 7.5 million!
I design hospitals and designed the IT systems in Sidra Medical and Research in Education City, Doha Qatar. We deployed the Da Vinci robotic surgery system in the surgical suite, and RFID to track critical medical equipment and devices on patients undergoing surgery which contained medical history information and the surgical procedure the patient was to undergo. They used close proximity readers for RF identification. With the GTCH technology they are planning to use radio waves which I believe will increase the range and wide area network capability. JMHO!
AI and IoT in Hospitals
How AI and IoT Are Changing Daily Operations in Hospitals
Six different ways AI and IoT are beginning to change daily operations in hospitals
Kayla Matthews, Industry Voice
Apr 3rd, 2020
Hospitals naturally produce vast amounts of data. Patient monitors record information such as heart rate, blood pressure and temperature, while doctors and technicians produce visual data in the form of x-rays and CT scans. All of this information can be hugely valuable — but only if organizations access it at the right time and have the tools to analyze it in a crisis.
New AI and medical Internet of Things (IoT) technology can make this information as accessible as possible to doctors. As a result, they're transforming how hospitals run where adopted.
Here are six different ways AI and IoT are beginning to change daily operations in hospitals.
1. Improving Diagnostic Accuracy
Even some common or widespread diseases, like breast and lung cancer, can be difficult to diagnose. With these conditions, doctors must correctly identify potential tumors using images from a computed tomography (CT) scanner. Despite being the most effective means of diagnosis available, false positives and negatives are still common.
AI both improves the quality of these scans — stitching together images and cleaning up visual noise for a more complete and easier-to-read scan — and reads the scans themselves. In a few different studies, these AI algorithms have been more effective than radiologists at correctly identifying the signs of cancer in a CT scan.
2. Remote Patient Monitoring
Remote patient monitoring systems take advantage of IoT sensors' internet connectivity to provide doctors and nurses with updates on patient vitals. With these remote sensors, it's possible to track a patient's health from anywhere in the hospital and alert nurses and doctors to significant health events.
These IoT healthcare systems reduce the labor needed to keep track of a patient's health while they're in the hospital. Typically, nurses will need to manually record and log patient vitals every few hours, depending on their condition. With an automated monitoring system, these vitals are automatically recorded and logged, freeing up staff for more critical work.
As medical IoT technology improves, these systems are likely to become more common.
3. Reducing Need For Follow-Up Visits
A similar application of IoT technology can track patients' health once they leave the hospital, reducing the need for follow-up visits.
For example, at the University of Pittsburgh Medical Center Magee-Women’s Hospital, healthcare providers use IoT devices to track the blood pressure of women with pregnancy-related hypertension. Typically, a condition like this would require follow-up visits, even though those with the issue notice it often goes away after birth. With the IoT system in place, 57 percent of patients could skip their first follow-up visit.
4. Reducing Wait Times
IoT technology also reduces wait times in smart hospitals.
Automatic bed-tracking systems notify hospital workers when a bed is free, allowing administrative staff to admit emergency patients as quickly as possible. In one use case, Mt. Sinai was able to slash their admission waiting times in half by implementing one of these systems.
5. Identifying Critical Patients
When hospitals are stressed and reaching their capacity, identifying patients who need immediate attention becomes critical in providing the best possible care. This process isn't easy. Doctors and nurses must analyze vast amounts of patient information and make snap decisions, all while under significant pressure.
Fortunately, AI and IoT systems provide a helping hand in situations like these. Hospitals are using new AI-powered virtual assistants to save their sickest patients. These systems alert doctors when a patient's condition begins to deteriorate and provides them with an analysis of their vitals and conditions. In some cases, these AI hospital systems were able to catch problems that doctors missed.
A few different hospitals have already seen notable success with these AI programs — like, for example, lowering the death rate of patients in the ICU by 12 percent.
6. Tracking Medical Equipment
Lost medical equipment can be a significant expense for hospitals. For example, it's not uncommon for hospitals to lose three to seven wound therapy pumps utilized in negative pressure wound therapy each year. Replacements for these can cost $20,000 to $30,000 each.
With the right tracking systems in place, organizations can greatly reduce the risk of losing medical equipment, lowering costs and ensuring that pumps are available when needed.
New mobile pump devices now come with in-built RFID and GPS systems so that people can track them while in the hospital — and beyond if one is sent home with a patient. The RFID scanning system also automatically requests approval from insurance when a pump gets pulled off of the shelf for patient use. This process ensures that the patient will be pre-approved to take their device home if necessary.
AI and IoT Are Changing How Hospitals Are Run
New AI and IoT innovations allow hospitals to take full advantage of data, like CT scans and records of patient vitals. These systems allow doctors to monitor patient health remotely, even when they're not in the building, and identify which patients need immediate attention. They can also boost the accuracy of diagnoses for certain diseases — like breast and lung cancer.
HMBL is an “amazing paradigm shift,” with the consolidation of all types of transactions into a single APP.
Investors will not go wrong buying this stock.
Monday will be a wild ride!
Launching HUMBL App in 40 countries.
That is Huuuuuuge News!
Expect a “wild day” on Monday!
My guess .50 by close!
Somebody bought 2.5 million shares two minutes before the close. AWESOME!
Jump on the elevator. Going Up!
Once the web server goes in the technology is ready for prime time. Mobile measurement of vitals will revolutionize patient care.
Money Morning has a Bitcoin target price at $65000.00!
What a difference a year makes!
Last year they were developing products in search of an application. This year, they have products on the cusp of commercialization.
This stock was at .56 in January of last year. This stock has a lot of irons in the fire and is a grossly undervalued and expect it will retrace to a much higher level soon. With the action the past two months, expect this stock will move up very soon!
Wallet investor predicts a dime by end of next week!
I had one guy who bought Bitcoin when it was under $100.00. He said he used his Bitcoins to buy weed. He wished he had kept a few. LOL!